Si-Bone (SIBN) Short term Debt (2019 - 2022)
Si-Bone's quarterly Short term Debt came in at $1.5 million in Q3 2022, down 83.3% quarter-over-quarter from $8.7 million in Q1 2020.
Si-Bone has reported Short term Debt for 3 years, with the latest figure at $1.5 million in Q3 2022.
- For the quarter ending Q3 2022, Short term Debt changed N/A year-over-year to $1.5 million; the trailing twelve-month figure through Sep 2022 stood at $1.5 million (changed N/A YoY), and the FY2019 full-year result was $4.4 million, changed N/A from the prior year.
- Short term Debt for Q3 2022 stood at $1.5 million, down from $8.7 million in the prior quarter.
- The five-year high for Short term Debt was $8.7 million in Q1 2020, with the low at $1.5 million in Q3 2022.
- Average Short term Debt over 3 years is $4.8 million, with a median of $4.4 million recorded in 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.46 Mn |
| Mar 31, 2020 | 8.73 Mn |
| Dec 31, 2019 | 4.36 Mn |